Abstract

Familial Alzheimer's disease-associated mutations in presenilin 1 or 2 or amyloid precursor protein result in elevated beta-amyloid, beta-amyloid accumulation, and plaque formation in the brains of affected individuals. By crossing presenilin 1 transgenic mice carrying the A246E mutation with plaque-producing amyloid precursor protein K670N/M671L transgenic mice (Tg2576), we show that co-expression of both mutant transgenes results in acceleration of amyloid accumulation and associative learning deficits. At 5 months of age with no detectable plaque pathology, amyloid precursor protein transgenic animals are impaired in contextual fear learning following two pairings of conditioned and unconditioned stimuli but appear normal following a more robust five-pairing training. At 9 months of age when beta-amyloid deposition is evident, these mice are impaired following both two-pairing and five-pairing protocols. Mice carrying both transgenes are impaired in contextual fear conditioning at either age. All transgenic animal groups performed as well as controls in cued fear conditioning, indicating that the contextual fear learning deficits are hippocampus-specific. The associative learning impairments are coincident with elevated alpha 7 nicotinic acetylcholine receptor protein in the dentate gyrus. These findings provide two robust and rapid assays for beta-amyloid-associated effects that can be performed on young animals: impaired contextual fear learning and up-regulation of alpha 7 nicotinic receptors.

Highlights

  • On, Alzheimer’s disease (AD)1 presents clinically as impaired memory formation, yet despite intensive study the

  • Nomenclature for the transgenic animal lines is as follows: PS-1 refers to animals heterozygous for the PS-1 A246E transgene; amyloid precursor protein (APP) refers to animals heterozygous for the APP K670N/M671L transgene; PS-1/APP refers to animals heterozygous for both mutant transgenes

  • Nontransgenic control animals were littermates generated in the breeding for PS-1/APP transgenic animals

Read more

Summary

Introduction

Alzheimer’s disease (AD) presents clinically as impaired memory formation, yet despite intensive study the. We demonstrated that elevation of A␤ in vivo using an animal model for AD (Tg2576) [7], leads to the up-regulation of hippocampal ␣7 nAChR protein. Considering that ERK MAPK activity is necessary for rodent spatial learning, ␣7 nAChR up-regulation in hippocampus may serve as a biochemical marker for the synaptic plasticity impairments and learning and memory deficits in Tg2576 animals (8 –10). Our working model posits that hippocampus-dependent learning and memory impairments in AD arise because of increased A␤ burden and chronic activation of the ERK MAPK cascade in hippocampus through ␣7 nAChRs. We tested the hypothesis that transgenic animals in which A␤ is elevated to varying degrees will exhibit hippocampus-dependent behavioral impairments. DG, dentate gyrus; CS, conditioned stimulus; US, unconditioned stimulus; ANOVA, analysis of variance; df, degrees of freedom

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call